Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
8Greens is a consumer health and wellness brand focused on dietary supplements designed to help consumers increase daily greens intake. The company is best known for effervescent tablets and other supplement formats made with eight greens, including spinach, kale, aloe vera, wheatgrass, blue green algae, barley grass, chlorella, and spirulina. Its products are marketed for everyday nutrition and wellness support across areas such as immunity, metabolism, gut health, brain focus, and skin health. Founded by Dawn Russell, 8Greens developed as a direct-to-consumer supplement brand and was acquired by Grove Collaborative in March 2025. It now operates as part of Grove's wellness portfolio rather than as an independent drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 8Greens.